A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

Preoperative cisplatin/fluorouracil is used for the treatment of localised oesophageal carcinoma. This phase II study aimed to assess the efficacy and safety of administering preoperative epirubicin/cisplatin/capecitabine (ECX). Patients with stage II or III oesophageal/gastro-oesophageal junctional...

Descripción completa

Detalles Bibliográficos
Autores principales: Starling, N, Okines, A, Cunningham, D, Allum, W, Wotherspoon, A, Benson, M, Thompson, J, Thomas, J, Brown, G, Riddell, A, Stavridi, F, Ashley, S, Oates, J, Chau, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695693/
https://www.ncbi.nlm.nih.gov/pubmed/19436301
http://dx.doi.org/10.1038/sj.bjc.6605070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695693/
https://www.ncbi.nlm.nih.gov/pubmed/19436301
http://dx.doi.org/10.1038/sj.bjc.6605070

Ejemplares similares